Wartsila Oyj Abp (0IKJ)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 27.14 |
|---|---|
| 52-week range | 25.14 – 40.49 |
| Return, 1 month / 3 months | −7.3% / −10.6% |
| Return, 1 year / 3 years | +5.7% / +205.5% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 37.3% |
| Worst drawdown (1 year) | -30.5% |
| Average daily value traded | 10.37M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wartsila Oyj Abp is a Finnish engineering company based in Helsinki that builds power systems for ships and power plants. It makes marine engines, propulsion equipment and automation systems for shipbuilders and shipping operators, and supplies engines and generating equipment for utilities and industrial customers that produce electricity. The company also provides maintenance and lifecycle services for the equipment it delivers, serving customers in the marine and energy markets around the world.
The shares are listed on the London Exchange in UK under the code 0IKJ, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wartsila Oyj Abp (0IKJ) trades on the London Exchange in UK. It last closed at EUR 27.14 on 23 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 2,552 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.7% and over the last three months it fell 10.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.1% | ||
| From 52-week high | -31.0% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.6% | ||
| 6-month return | -30.3% | ||
| 12-month return, skipping the last month | 14.0% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.5% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 10.37M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.6% |
|---|---|
| 1 month | −7.3% |
| 3 months | −10.6% |
| 6 months | −30.3% |
| 1 year | +5.7% |
| 3 years | +205.5% |
| 5 years | +186.7% |
Signals
| 50-day / 200-day average | 28.90 / 31.97 |
|---|---|
| Golden / death cross (60 days) | Death, 55 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.94 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | EUR 0.2700 |
| 13 Mar 2026 | EUR 0.5200 |
| 16 Sep 2025 | EUR 0.2200 |
| 14 Mar 2025 | EUR 0.2200 |
| 10 Sep 2024 | EUR 0.1600 |
| 8 Mar 2024 | EUR 0.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.